Johnson & Johnson to Participate in Goldman Sachs 43^rd Annual Global Healthcare Conference

New Brunswick, NJ (May 12, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43^rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16^th. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.